Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus

Drugs in Context

article

Alexander KC Leung¹  Tara McMillan²  Andrea Human²  Joseph M Lam³ 

[1]he University of Calgary, The Alberta Children’s Hospital

[2]British Columbia Children’s Hospital, University of British Columbia

[3]Department of Dermatology and Skin Sciences, University of British Columbia

关键词: chloroquine;    COVID-19;    dermatologic disorders;    melanin;    rheumatologic disorders;   

DOI  :  10.7573/dic.2020-5-8

学科分类：社会科学、人文和艺术（综合）

来源: C S F Medical Communications Ltd.

【 摘 要 】

Hydroxychloroquine (HCQ)-induced hyperpigmentation is uncommon but is increasingly recognized. To our knowledge, HCQ-induced hyperpigmentation has not been reported in the pediatric age group. Herein, we present the case of a 14-year-old girl with systemic lupus erythematosus, who developed hyperpigmentation on her shins and dorsum of the left foot, approximately 3 years after initiating treatment with HCQ. Physicians who treat children with HCQ for reasons such as rheumatologic disorders, dermatologic disorders and, more recently, coronavirus disease-19 should be aware of this less-known side effect of HCQ.

【 授权许可】

CC BY-NC-ND